ZymoGenetics: Clinical Trials

12 trials sponsored by ZymoGenetics, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed, 1 terminated, 1 unknown. 5 Phase 2, 4 Phase 1, 3 Phase 3, 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 25Completed 3, Terminated 1, Unknown 1
Phase 14Completed 4
Phase 33Completed 2, Terminated 1
Phase 42Completed 2

Follow ZymoGenetics: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety Study of PEG-rIL-29 Plus Ribavirin to Treat Chronic Hepatitis C Virus Infection
PEG-rIL-29, Peginterferon alfa-2a, Ribavirin - Hepatitis C, Chronic
Phase 2UnknownZymoGenetics6002010-05-012011-12-05
Safety and Immunogenicity Study of Recombinant Thrombin (rThrombin) in Pediatric Participants
rThrombin, 1000 IU/mL - Blood Loss, Surgical
Phase 4CompletedZymoGenetics302009-03-012012-01-26
Immunogenicity and Safety Study of rThrombin in Surgical Hemostasis
rThrombin, 1000 IU/mL - Blood Loss, Surgical
Phase 4CompletedZymoGenetics312009-01-012011-12-08
Interleukin-21 in Treating Patients With Metastatic or Recurrent Malignant Melanoma
recombinant human interleukin-21, immunohistochemistry staining method, laboratory biomarker analysis - Melanoma (Skin)
Phase 2CompletedNCIC Clinical Trials Group402007-12-132023-08-04
The Efficacy and Safety of Atacicept in Combination With Mycophenolate Mofetil Used to Treat Lupus Nephritis
Atacicept, Mycophenolate mofetil, Placebo - Lupus Nephritis
Phase 2 / Phase 3TerminatedEMD Serono62007-12-012016-03-23
Study of PEG-rIL-29 (or PEG-IFN Lambda) in Subjects With Chronic Hepatitis C Virus Infection
PEGylated recombinant interleukin 29 (PEG-rIL-29) - Hepatitis C, Chronic
Phase 1CompletedZymoGenetics562007-12-012009-10-07
Immunogenicity and Safety Study of Topical Recombinant Thrombin in Surgical Hemostasis
rThrombin - Spinal Surgery, Vascular Surgery
Phase 3CompletedZymoGenetics2342007-06-012012-01-13
Study of Recombinant Interleukin 21 in Combination With Sorafenib for Metastatic Renal Cell Carcinoma
rIL-21 only, rIL-21 + sorafenib - Carcinoma, Renal Cell
Phase 1 / Phase 2CompletedZymoGenetics522006-10-012009-05-27
Study of Recombinant Human Thrombin for Bleeding During Autologous Skin Grafting
rThrombin - Surgical Hemostasis
Phase 2CompletedZymoGenetics722006-08-012009-03-09
Study of Recombinant Interleukin 21 in Combination With Rituxan for Non-Hodgkin's Lymphoma
recombinant human interleukin 21 and rituximab - Lymphoma, Non-Hodgkin
Phase 1CompletedZymoGenetics232006-06-012008-09-05
Study of Recombinant Human Thrombin for Bleeding During Surgery
rThrombin, bovine thrombin - Surgical Hemostasis
Phase 3CompletedZymoGenetics4012005-10-012009-03-09
Study of Interleukin-21 for Metastatic Malignant Melanoma and Metastatic Kidney Cancer
Recombinant Human Interleukin-21 - Melanoma, Kidney Neoplasms
Phase 1CompletedZymoGenetics432004-05-012009-03-09

Conditions studied

Blood Loss, Surgical (2)  ·  Carcinoma, Renal Cell (2)  ·  Hepatitis C (2)  ·  Hepatitis C, Chronic (2)  ·  Infections (2)  ·  Melanoma (2)  ·  Virus Diseases (2)  ·  Kidney Neoplasms (1)  ·  Liver Diseases (1)  ·  Lupus Nephritis (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Neoplasm Metastasis (1)  ·  Nephritis (1)

Interventions

recombinant human thrombin (5)  ·  Thrombin (3)  ·  peginterferon lambda-1a (2)  ·  Adrenal Cortex Hormones (1)  ·  Immunohistochemistry (1)  ·  Mycophenolic Acid (1)  ·  Ribavirin (1)  ·  Rituximab (1)  ·  Sorafenib (1)  ·  TACI receptor-IgG Fc fragment fusion protein (1)  ·  peginterferon alfa-2a (1)

Countries

United States (11)  ·  Canada (3)  ·  Australia (1)  ·  Austria (1)  ·  Czechia (1)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  Malaysia (1)  ·  Poland (1)  ·  Puerto Rico (1)  ·  Romania (1)  ·  Singapore (1)  ·  Spain (1)  ·  Taiwan (1)

Top investigators

Allan Alexander, MD (1)  ·  Allan Alexander, MD, CPI (1)  ·  Diana F Hausman, MD (1)  ·  Diana Hausman, MD (1)  ·  Fred Weaver, MD (1)  ·  Jan Hillson, MD (1)  ·  Kenneth Renkens, MD (1)  ·  Kevin Foster, MD (1)  ·  Muriel Siadak, PA-C (1)  ·  Naomi Hunder, MD (1)  ·  Neil Singla, MD (1)  ·  Teresa M. Petrella (1)  ·  Thomas C Reynolds, MD, PhD (1)  ·  William Chapman, MD (1)

Results publications

PMID 17660072, PMID 18440754, PMID 19651065, PMID 20980172, PMID 22008340, PMID 22325903, PMID 22915661, PMID 24829759, PMID 25042797, PMID 25043197, PMID 38837237

NIH funding

2009 (1)